Clinical trial
Multihance at 3 Tesla (3T) in Brain Tumors
NCT00395863 · Bracco Diagnostics, Inc, Industry · Completed
Key facts
| NCT number | NCT00395863 |
|---|---|
| Title | Multihance at 3 Tesla (3T) in Brain Tumors |
| Official title | A Phase IV Double-blind Multicenter Randomized Crossover Study to Compare 0.10 mmol/kg of Multihance With 0.10 mmol.kg of Magnevist in Magnetic Resonance Imaging(MRI) of the Brain at 3T |
| Lead sponsor | Bracco Diagnostics, Inc, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Brain Tumor |
| Intervention type | Drug |
| Interventions | Multihance, Arm 2 - Magnevist |
| Enrollment | 46 |
| Start date | Nov 1, 2006 |
| Primary completion | Feb 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Nov 6, 2006 |
| Last update posted | Nov 5, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: